Table 2.
Characteristics of pandemic period patients.
| Variables | Non-COVID-19 patients (n = 528) | COVID-19 patients (n = 142) | p-Value |
|---|---|---|---|
| CVI | 26 (4.92%) | — | 0.058a |
| ESKD | 61 (11.55%) | — | 0.01a |
| Symptomatic carotid stenosis | 79 (14.96%) | 21 (14.78%) | 0.95a |
| Acute limb ischemia | 58 (10.98%) | 44 (30.98%) | <0.0001a |
| Other pathology | 30 (5.68%) | 9 (6.33%) | 0.76a |
| Peripheral arterial disease | |||
| Suprainguinal revascularization | 70 (13.25%) | 18 (12.67%) | 0.85a |
| Infrainguinal revascularization | 103 (19.50%) | 23 (16.19%) | 0.37a |
| Amputation | 54 (10.22%) | 36 (25.35%) | <0.0001a |
| Endovascular treatment | 38 (7.19%) | — | 0.02a |
| Age mean ± SD (min–max) | 65.75 ± 12.17 (19–98) | 67.19 ± 11.46 (36–84) | 0.33b |
| Sex (M/F) | 79.35%/20.65% | 57.04%/42.96% | <0.0001a |
| Duration of hospital stay (days), median [interquartile range] | 6 [4–9] | 8 [7–11] | 0.001c |
| ICU admission, no. (%) | 135 (25.56%) | 68 (47.88%) | <0.0001a |
| Deaths, no. (%) | 77 (14.58%) | 45 (31.69%) | <0.0001a |
CVI, chronic venous insufficiency; ESKD, end-stage kidney disease; ICU, intensive care unit; SD, standard deviation.
a
Chi-square test.
b
Student’s t-test.
c
Mann–Whitney test.